SCHEMBL23965357

SCHEMBL23965357

CC1(C)OB(c2nc(-c3ccc(-c4cccc5oc6ccccc6c45)cc3)nc(-c3ccc4ccccc4c3)n2)OC1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 2/20 0.44
LIPG Q9Y5X9 2/20 0.44
BACE1 P56817 1/20 0.33
ALDH1A1 P00352 3/20 0.31
HSD17B10 Q99714 3/20 0.31
CYP1A2 P05177 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
KMT2A Q03164 1/20 0.31
TERT O14746 1/20 0.31
HPGD P15428 2/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
GAA P10253 1/20 0.30
AURKA O14965 1/20 0.30
AURKB Q96GD4 1/20 0.30
MET P08581 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965282 0.88 LPL (0.49) LPLLIPGALDH1A1HSD17B10CYP1A2
SCHEMBL26272401 0.87 LPL (0.47) LPLLIPGCYP1A2MEN1KMT2A
SCHEMBL26272416 0.86 LIPG (0.41) LPLLIPGBACE1ALDH1A1HSD17B10
SCHEMBL28851965 0.86 LPL (0.37) LPLLIPGALDH1A1HSD17B10SMN1; SMN2
SCHEMBL21148591 0.85 ALDH1A1 (0.40) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL23385015 0.85 ALDH1A1 (0.40) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL23820721 0.83 BACE1 (0.39) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL23385221 0.83 ALDH1A1 (0.44) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL24315133 0.83 BACE1 (0.39) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL26374298 0.83 BACE1 (0.39) BACE1ALDH1A1HSD17B10CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 LPL 2546/4885LIPG 3610/4885BACE1 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.